2024
A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States
Poghosyan H, Sarkar S, Richman I, Pietrzak R, Carter-Bawa L, Cooley M. A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States. JTO Clinical And Research Reports 2024, 5: 100705. PMID: 39282662, PMCID: PMC11402037, DOI: 10.1016/j.jtocrr.2024.100705.Peer-Reviewed Original ResearchLung cancer screeningLung cancer screening utilizationScreening utilizationBehavioral Risk Factor Surveillance SystemRates of lung cancer screeningRisk Factor Surveillance SystemScreening-eligible individualsCancer screening utilizationLung cancer burdenPopulation-based dataMultivariate logistic regressionCancer screeningCancer burdenImpact healthcareNational ratesIncreased oddsLogistic regressionNationwide effortSurveillance systemCOVID-19COVID-19 pandemicLung diseaseBrief reportNo sex differencesUnited States
2021
Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women
Upneja A, Long JB, Aminawung JA, Kyanko KA, Kunst N, Xu X, Busch SH, Gross CP, Richman IB. Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women. Journal Of General Internal Medicine 2021, 37: 1870-1876. PMID: 34595682, PMCID: PMC8483166, DOI: 10.1007/s11606-021-07132-6.Peer-Reviewed Original ResearchConceptsWomen 75Older womenBreast cancerAdditional cancersSubsequent imagingWomen 67Stage ITime of diagnosisEarly-stage cancerHigh rateCancer detectionConclusionsBreast cancerPrior cancerPotential confoundersScreening outcomesHealth outcomesService beneficiariesComparative effectivenessScreening mammogramsAge groupsCancerLogistic regressionResultsOur studyWomenBreast tomosynthesisComparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old
Richman IB, Long JB, Hoag JR, Upneja A, Hooley R, Xu X, Kunst N, Aminawung JA, Kyanko KA, Busch SH, Gross CP. Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old. Journal Of The National Cancer Institute 2021, 113: 1515-1522. PMID: 33822120, PMCID: PMC8757313, DOI: 10.1093/jnci/djab063.Peer-Reviewed Original ResearchConceptsHigher cancer detection rateCancer detection rateBreast cancer screeningCancer screeningScreening outcomesBreast cancer screening outcomesDigital breast tomosynthesisCancer screening outcomesPopulation-level adoptionReal-world cohortMultivariable logistic regressionHigher biopsy ratesPatient-level analysisPopulation health impactDetection rateIncident cancerClinical outcomesWomen 40Biopsy rateObservational studyComparative effectivenessLogistic regressionYoung womenPrivate health insurersWomen
2019
Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography.
Busch SH, Hoag JR, Aminawung JA, Xu X, Richman IB, Soulos PR, Kyanko KA, Gross CP. Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography. American Journal Of Public Health 2019, 109: 762-767. PMID: 30896987, PMCID: PMC6459654, DOI: 10.2105/ajph.2019.304967.Peer-Reviewed Original ResearchConceptsSupplemental screeningCancer detectionMore breast cancersMagnetic resonance imagingPossible benefitsBreast cancerSupplemental ultrasoundBreast biopsySupplemental testingResonance imagingUse of ultrasoundLogistic regressionScreening mammographyCancer diagnosisUltrasoundSignificant differencesSupplemental testsMore ultrasoundMammographyUS statesBreast cancer detectionMammogramsAssociationScreeningBiopsy
2012
European genetic ancestry is associated with a decreased risk of lupus nephritis
Richman IB, Taylor KE, Chung SA, Trupin L, Petri M, Yelin E, Graham RR, Lee A, Behrens TW, Gregersen PK, Seldin MF, Criswell LA. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis & Rheumatism 2012, 64: 3374-3382. PMID: 23023776, PMCID: PMC3865923, DOI: 10.1002/art.34567.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusRenal diseaseLupus nephritisSLE patientsSingle nucleotide polymorphismsSocioeconomic statusEuropean genetic ancestryCross-sectional studyEuropean ancestrySocioeconomic factorsCandidate risk allelesSubset of participantsMeasures of SESDisease durationLupus erythematosusDecreased riskLogistic regressionDiseaseRisk allelesGenetic ancestryNephritisEuropean descentPatientsCandidate genesAfrican Americans